BNGO Bionano Yalpi foyda bo'yicha rentabellik

BNGO (Bionano Genomics) - kompaniyaning tovar belgisi

Bionano Genomics, Inc. (BNGO) rahbariyati zararlilikni qoplash nuqtasiga erishish uchun xarajatlarni kamaytirishga intilmoqda, biroq yuqori R&D xarajatlari va erkin pul oqimining tanqisligi moliyaviy bosimni keltirib chiqarmoqda. Val gross profit margin samaradorlik dinamikasini aks ettiradi, bunda 48.00 qiymati joriy darajani tavsiflaydi. Zamonaviy laboratoriyalarda to'liq akademik erkinlikka ega bo'lgan yetakchi olimlar genom xaritalash texnologiyalarining rivojlanishiga turtki bermoqdalar.

BNGO Bionano Yalpi marja (04.07.2022 - 20.11.2026)

Bionano (BNGO) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Fundamental baholash:BNGO - bionanogenomics.com
Bionano Genomics Inc. seriyali mahsuloti

Bionano Genomics, Inc. (BNGO) Saphyr tizimini joriy etish orqali strukturaviy variatsiya diagnostikasi sohasida ustunlikka intilmoqda. Moslashtirilgan yalpi foydani tahlil qilish orqali investorlar ushbu texnologiyalarning monetizatsiya samaradorligini bevosita ishlab chiqarish xarajatlariga nisbatan baholaydilar. Ushbu ko'rsatkich tushum va sotilgan tovarlar tannarxi orasidagi farq sifatida hisoblanadi hamda uzoq muddatli barqarorlikni ta'minlash uchun biznesning har bir mahsulot birligidan foyda olish qobiliyatini namoyish etadi.

Asosiy raqobatchilar

Yalpi foyda bo'yicha rentabellik Tempus AI Inc|QGEN (Qiagen NV) - Yalpi marja|Yalpi foyda bo'yicha rentabellik Ionis Pharma (IONS)|Yalpi rentabellik Repligen Corp (RGEN)|RNA - Yalpi foyda marjasi|crisprtx.com - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi WGS|RARE - Yalpi rentabellik|Beam Tx (BEAM) - Yalpi foyda bo'yicha rentabellik|SRPT (Sarepta Therapeutics Inc) - Yalpi foyda bo'yicha rentabellik|TWST: Yalpi foyda koeffitsiyenti|TXG (10xgenomics.com) - Yalpi marja|NTLA (Intellia Therapeutics, Inc.) - Yalpi foyda koeffitsiyenti|Yalpi rentabellik Stoke Corp (STOK)|Yalpi foyda bo'yicha sotuv rentabelligi BioLife|Yalpi marja WVE (Wave Life Sciences Ltd)|MAZE: Sotuvning yalpi rentabelligi|Sionna Therapeutics, Inc. - Yalpi marja|Yalpi foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Yalpi foyda bo'yicha rentabellik|QURE - Yalpi foyda bo'yicha sotuv rentabelligi|MGTX (MeiraGTx Corp) - Yalpi marja|Yalpi foyda marjasi REGENXBIO Inc. RGNX|Yalpi rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Sotuvning yalpi rentabelligi|Yalpi rentabellik Pacific Biosciences PACB|Yalpi foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Yalpi marja|Rocket Pharmaceuticals - Yalpi foyda koeffitsiyenti|Sotuvning yalpi rentabelligi 4D Molecular Therapeutics, Inc.|Yalpi foyda marjasi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Yalpi marja|Yalpi foyda marjasi Editas EDIT|Yalpi marja SLN|ProQR Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja CDXS (Codexis, Inc.)|SGMO: Sotuvning yalpi rentabelligi|Nautilus Biotechnology - Yalpi marja|Yalpi foyda normasi MGX (Metagenomi, Inc)|DTIL: Yalpi marja|GBIO: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Boundless Bio Inc.|Yalpi foyda bo'yicha rentabellik Exicure (XCUR)|Yalpi marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Yalpi foyda normasi|Mustang Bio, Inc. - Yalpi foyda bo'yicha rentabellik|RNAZ - Yalpi foyda bo'yicha rentabellik|Applied DNA - Yalpi marja|Yalpi foyda marjasi Bluebird Bio|ImmunoPrecise (IPA) - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik OMGA (Omega)|Yalpi rentabellik Singular Genomics Systems|Yalpi foyda marjasi regulusrx.com RGLS|Yalpi rentabellik Syros Pharmaceuticals Inc. (SYRS)|Yalpi foyda bo'yicha sotuv rentabelligi Codex DNA|Yalpi rentabellik TRACON TCON|Unity Biotechnology, Inc - Yalpi rentabellik